Reaction
Gluten Sensitivity reporting signals
As of the last recalculation, Gluten Sensitivity appears in 1,406 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is LIOTHYRONINE SODIUM (PRR 32.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Liothyronine Sodium | 19 | 32.7 | 32.8 |
| Thyroid, Porcine | 10 | 14.0 | 14.0 |
| Olmesartan Medoxomil | 28 | 11.7 | 11.8 |
| Sodium Oxybate | 34 | 7.8 | 7.8 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 6 | 7.1 | 7.2 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 4 | 6.9 | 6.9 |
| Lurasidone Hydrochloride | 9 | 6.4 | 6.4 |
| Vortioxetine | 7 | 6.1 | 6.1 |
| Methylphenidate | 11 | 5.7 | 5.7 |
| Fremanezumab-Vfrm | 3 | 3.9 | 3.9 |
| Abemaciclib | 5 | 3.7 | 3.7 |
| Copper | 3 | 1.0 | 1.0 |